NAVIDEA BIOPHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Navidea Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $19.7K, a 89.4% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $136K, a 74.5% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $301K, a 36.1% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $471K, a 104% increase from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $231K, a 0.43% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $301K -$170K -36.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $471K +$240K +104% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $231K -$1K -0.43% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $232K -$75K -24.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $307K -$87K -22.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 $394K +$116K +41.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 $278K -$2.12M -88.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $2.4M +$800K +50% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $1.6M Jan 1, 2014 Dec 31, 2014 8-K 2017-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.